T. Rowe Price Associates’s CAREFUSION CORPORATION CFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-15,947,123
Closed -$946M 2596
2014
Q4
$946M Sell
15,947,123
-2,288,483
-13% -$131M 0.2% 123
2014
Q3
$825M Buy
18,235,606
+3,819,738
+26% +$172M 0.18% 143
2014
Q2
$639M Buy
14,415,868
+4,045,650
+39% +$167M 0.14% 181
2014
Q1
$417M Buy
10,370,218
+60,690
+0.6% +$2.46M 0.09% 257
2013
Q4
$411M Buy
10,309,528
+86,900
+0.9% +$3.38M 0.09% 257
2013
Q3
$377M Sell
10,222,628
-13,300
-0.1% -$496K 0.09% 260
2013
Q2
$377M Buy
+10,235,928
New +$362M 0.1% 251

Other funds holding CFN

T. Rowe Price Associates's CFN Position: Q1 2015 in Review

T. Rowe Price Associates sold out of CAREFUSION CORPORATION (CFN) in Q1 2015, closing a stake of 15,947,123 shares — an estimated $946M sold.

T. Rowe Price Associates first reported a position in CFN in Q2 2013 and held it in 7 quarters. The position peaked at $946M in Q4 2014. 3 funds tracked by Wall St. Rank hold CFN as of Q1 2015.

  • T. Rowe Price Associates reported no remaining CAREFUSION CORPORATION position as of Q1 2015 after selling out during the quarter.
  • T. Rowe Price Associates sold 15,947,123 CAREFUSION CORPORATION shares in Q1 2015, an estimated $946M.
  • T. Rowe Price Associates first reported a position in CAREFUSION CORPORATION in Q2 2013 and held it in 7 quarters.
  • T. Rowe Price Associates's CAREFUSION CORPORATION position peaked at $946M in Q4 2014.
  • 3 funds tracked by Wall St. Rank held CAREFUSION CORPORATION as of Q1 2015.

Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.